Hims and Hers Health Inc. rose after the telehealth company said it was in talks with Novo Nordisk A/S to sell its forthcoming obesity pill on the telehealth site.

Hims & Hers Health (HIMS) stock rises as the company renews talks with Novo Nordisk (NVO) to sell the pharma giant's obesity drug Wegovy. Read more here.

I expect Hims & Hers Health, Inc. to show stabilizing ARPU around $54+ per user in Q3 despite the GLP-1 slowdown, which could signal meaningful upside to the company's conservative 2030 guidance. I'm ...

Shares of Hims & Hers Health ($HIMS) rallied on Tuesday after management said it’s in discussions with Novo Nordisk ($NVO) to ...

Murkowski votes ‘no’ on motion to adjourn to protest shutdown Epstein Survivor's Family Declares 'Victory' After Prince Andrew Is Stripped Of Royal Title ‘Luckily, I did not mix our finances’: My ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Carvana Co (Symbol: CVNA), where a total volume of 28,215 contracts has been ...

Direct-to-consumer (DTC) telehealth companies remove barriers to care, but questions remain regarding patient safety and proper information.

WASHINGTON – For New Hampshire Sen. Maggie Hassan, it felt personal watching more than 120 jobs tied to special education disappear during the U.S. government shutdown. President Donald Trump ordered ...

The U.S. Department of Education is in talks to move oversight of special education programs to another federal agency. An Education Department official said this week that the agency is working to ...

President Donald Trump endorsed Kentucky veteran Ed Gallrein to take on and oust U.S. Rep. Thomas Massie from Congress “ASAP” in an Oct. 17 Truth Social post. "The incredible people of Kentucky's 4th ...